METHODS OF PREDICTING GABAA RECEPTOR EFFICACIES FOR FLAVONOID COMPOUNDS AND USES THEREFOR

Details for Australian Patent Application No. 2003257369 (hide)

Owner PHAMACOGENETICS LIMITED

Inventors XUE, Hong; HUEN, Shing, Yan, Michael

Pub. Number AU-A-2003257369

PCT Number PCT/CN03/00693

PCT Pub. Number WO2004/016265

Priority 60/404,621 19.08.02 US

Filing date 19 August 2003

Wipo publication date 3 March 2004

International Classifications

A61K 031/352 - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 025/20 Drugs for disorders of the nervous system

A61P 025/22 Drugs for disorders of the nervous system

A61P 025/08 Drugs for disorders of the nervous system

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 60/404,621 19.08.02 US

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2003257369

19 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003257370-METHODS OF TREATING BENZODIAZEPINE SITE (BZD-S) ASSOCIATED SYNDROMES USING 2' HYDROXYFLAVONOIDS

2003257368-FLUORESCENT MAGNETIC NANOPARTICLES AND PROCESS OF PREPARATION